Target, Zoom, Occidental, Workday And More: U.S. Stocks To Watch

Benzinga2023-02-28

With US futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Target Corporation (NYSE:TGT) to post quarterly earnings at $1.40 per share on revenue of $30.67 billion before the opening bell. Target shares dropped 0.1% to $166.69 in premarket trading Tuesday.
  • Zoom Video Communications Inc (NASDAQ:ZM) reported better-than-expected Q4 results and issued strong guidance. Zoom shares climbed 6.5% to $78.52 in premarket trading Tuesday.
  • Analysts are expecting AutoZone, Inc. (NYSE:AZO) to have earned $21.91 per share on revenue of $3.56 billion for the latest quarter. The company will release earnings before the markets open. AutoZone shares rose 0.1% to $2,575.00 in after-hours trading Monday.
  • Workday Inc (NASDAQ:WDAY) reported upbeat results for its fourth quarter, but said it expects the environment to remain uncertain in the near term. Workday shares dropped 2.5% to $180.35 in premarket trading Tuesday.
  • Analysts expect HP Inc. (NYSE:HPQ) to post quarterly earnings at $0.74 per share on revenue of $14.15 billion after the closing bell. HP shares gained 0.3% to $29.48 in after-hours trading Monday.
  • U.S. oil producer Occidental Petroleum Corp (NYSE:OXY) said it would sharply raise spending this year, including on its direct air capture carbon-reduction project, which has been delayed to 2025. The Houston-based company posted fourth-quarter profit below Wall Street estimates on lower energy prices and higher costs. The direct air capture (DAC) project is closely watched by investors as a potential moneymaker. Occidental shares dropped 1% to $58.35 in premarket trading Tuesday.
  • Ocugen (NASDAQ:OCGN) said it submitted an investigational new drug application with the Food and Drug Administration to start a Phase 1 clinical trial of vision treatment OCU200. The trial would look at OCU200 as a treatment of diabetic macular edema, or DME. Ocugen shares jumped 15.8% to $1.13 in premarket trading Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
3